All News about AmgenVia Benzinga
Via Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $500 Today
November 22, 2022
Via Benzinga
Credit Suisse Sets Bearish Tone For Amgen; Says Current Setup Not Ideal For Growth
November 18, 2022
Via Benzinga
What 7 Analyst Ratings Have To Say About Amgen
November 18, 2022
Via Benzinga
Analyst Ratings for Amgen
November 18, 2022
Via Benzinga
Where Amgen Stands With Analysts
November 18, 2022
Via Benzinga
Amgen Earnings Perspective: Return On Invested Capital
November 17, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
November 18, 2022
Via Benzinga
Biotech Sector Witnessing Growing Revenue Potential in Ongoing Battle Against Pancreatic Cancer
November 15, 2022
Topics
Death
Exposures
Death
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|